A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression

BACKGROUND: Early progression after the first-line R-CHOP treatment leads to a very dismal outcome and necessitates alternative treatment for patients with diffuse large B-cell lymphoma (DLBCL). This study aimed to develop a genetic predictive model for early progression and evaluate its potential i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jialin, Yan, Zheng, Zhang, Jiuyang, Zhou, Wenping, Yao, Zhihua, Wang, Haiying, Chu, Junfeng, Yao, Shuna, Zhao, Shuang, Zhang, Peipei, Xu, Yuanlin, Xia, Qingxin, Ma, Jie, Wei, Bing, Yang, Shujun, Liu, Kangdong, Guo, Yongjun, Liu, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448459/
https://www.ncbi.nlm.nih.gov/pubmed/32864130
http://dx.doi.org/10.1186/s40364-020-00214-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448459/
https://www.ncbi.nlm.nih.gov/pubmed/32864130
http://dx.doi.org/10.1186/s40364-020-00214-3

Ejemplares similares